US › Healthcare

CERo Therapeutics Holdings, Inc. Common Stock (CERO)

US · Healthcare · Biotechnology

$0.01-15.79%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-5.9M

Profit YoY

-15.3%

EPS

$-9.10

EPS estimate

$-4.35

EPS came in at -9.10 against a street estimate of -4.35 — a miss of 109.2%.

Key statistics

Market cap

$451,124

P/E

0.0

Forward P/E

0.0

P/B

0.00

Book value

$-0.46

EPS (TTM)

$9.04

52-week high

$8.90

52-week low

$0.01

50-day MA

$0.01

200-day MA

$0.17

Beta

0.16

Analyst view

Analysts rate CERo Therapeutics Holdings, Inc. Common Stock a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $30.00.

Shareholding

Insiders

4.13%

Institutions

0.14%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CERo Therapeutics Holdings, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.